A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells

Stroke remains a significant unmet condition in the USA and throughout the world. To date, only approximately 3% of the population suffering an ischemic stroke benefit from the thrombolytic drug tissue plasminogen activator, largely due to the drug’s narrow therapeutic window. The last decade has wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Glover, Loren E., Tajiri, Naoki, Weinbren, Nathan L., Ishikawa, Hiroto, Shinozuka, Kazutaka, Kaneko, Yuji, Watterson, D. Martin, Borlongan, Cesar V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284662/
https://www.ncbi.nlm.nih.gov/pubmed/22389662
http://dx.doi.org/10.1007/s12975-011-0127-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284662/
https://www.ncbi.nlm.nih.gov/pubmed/22389662
http://dx.doi.org/10.1007/s12975-011-0127-8

Ejemplares similares